• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状严重急性呼吸综合征冠状病毒 2 感染的自然史和传播潜力。

The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

机构信息

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.

Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.

出版信息

Clin Infect Dis. 2020 Dec 17;71(10):2679-2687. doi: 10.1093/cid/ciaa711.

DOI:10.1093/cid/ciaa711
PMID:32497212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7314145/
Abstract

BACKGROUND

Little is known about the natural history of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

METHODS

We conducted a prospective study at a quarantine center for coronavirus disease 2019 in Ho Chi Minh City, Vietnam. We enrolled quarantined people with reverse-transcription polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection, collecting clinical data, travel and contact history, and saliva at enrollment and daily nasopharyngeal/throat swabs (NTSs) for RT-PCR testing. We compared the natural history and transmission potential of asymptomatic and symptomatic individuals.

RESULTS

Between 10 March and 4 April 2020, 14 000 quarantined people were tested for SARS-CoV-2; 49 were positive. Of these, 30 participated in the study: 13 (43%) never had symptoms and 17 (57%) were symptomatic. Seventeen (57%) participants imported cases. Compared with symptomatic individuals, asymptomatic people were less likely to have detectable SARS-CoV-2 in NTS collected at enrollment (8/13 [62%] vs 17/17 [100%]; P = .02). SARS-CoV-2 RNA was detected in 20 of 27 (74%) available saliva samples (7 of 11 [64%] in the asymptomatic group and 13 of 16 [81%] in the symptomatic group; P = .56). Analysis of RT-PCR positivity probability showed that asymptomatic participants had faster viral clearance than symptomatic participants (P < .001 for difference over the first 19 days). This difference was most pronounced during the first week of follow-up. Two of the asymptomatic individuals appeared to transmit SARS-CoV-2 to 4 contacts.

CONCLUSIONS

Asymptomatic SARS-CoV-2 infection is common and can be detected by analysis of saliva or NTSs. The NTS viral loads fall faster in asymptomatic individuals, but these individuals appear able to transmit the virus to others.

摘要

背景

无症状严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的自然史知之甚少。

方法

我们在越南胡志明市的 2019 年冠状病毒病检疫中心进行了一项前瞻性研究。我们招募了经逆转录聚合酶链反应(RT-PCR)确诊 SARS-CoV-2 感染的被隔离者,收集临床数据、旅行和接触史以及在入组时和每天采集的唾液进行 RT-PCR 检测。我们比较了无症状和有症状个体的自然史和传播潜力。

结果

在 2020 年 3 月 10 日至 4 月 4 日期间,对 14000 名被隔离者进行了 SARS-CoV-2 检测;49 例呈阳性。其中 30 人参加了这项研究:13 人(43%)从未出现症状,17 人(57%)出现症状。17 名(57%)参与者为输入性病例。与有症状的个体相比,无症状个体在入组时采集的 NTS 中更不可能检测到 SARS-CoV-2(8/13 [62%] vs 17/17 [100%];P=0.02)。在 27 份可获得的唾液样本中,20 份(74%)检测到 SARS-CoV-2 RNA(无症状组 7/11 [64%],有症状组 13/16 [81%];P=0.56)。RT-PCR 阳性率分析显示,无症状参与者的病毒清除速度快于有症状参与者(第 19 天之前的差异 P<0.001)。这种差异在随访的第一周最为明显。2 名无症状个体似乎将 SARS-CoV-2 传播给了 4 名接触者。

结论

无症状 SARS-CoV-2 感染很常见,可通过分析唾液或 NTS 进行检测。无症状个体的 NTS 病毒载量下降更快,但这些个体似乎能够将病毒传播给其他人。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/5efc2cca178e/ciaa711f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/bea2330f4f8f/ciaa711f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/1f458f2b7661/ciaa711f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/eaf4eb9b562d/ciaa711f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/929b8f0eb9ee/ciaa711f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/5efc2cca178e/ciaa711f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/bea2330f4f8f/ciaa711f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/1f458f2b7661/ciaa711f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/eaf4eb9b562d/ciaa711f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/929b8f0eb9ee/ciaa711f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2490/7745004/5efc2cca178e/ciaa711f0005.jpg

相似文献

1
The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection.无症状严重急性呼吸综合征冠状病毒 2 感染的自然史和传播潜力。
Clin Infect Dis. 2020 Dec 17;71(10):2679-2687. doi: 10.1093/cid/ciaa711.
2
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
3
The First 100 Days of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Control in Vietnam.越南对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的前 100 天控制。
Clin Infect Dis. 2021 May 4;72(9):e334-e342. doi: 10.1093/cid/ciaa1130.
4
Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.用于检测有轻微症状和无症状患者的 SARS-CoV-2 的唾液样本。
J Med Virol. 2021 May;93(5):2932-2937. doi: 10.1002/jmv.26821. Epub 2021 Feb 9.
5
Epidemiological and viral features of a cohort of SARS-CoV-2 symptomatic and asymptomatic individuals in an area of the Colombian Caribbean.哥伦比亚加勒比地区一组有症状和无症状 SARS-CoV-2 个体的流行病学和病毒特征。
Ann Clin Microbiol Antimicrob. 2020 Dec 7;19(1):58. doi: 10.1186/s12941-020-00397-5.
6
Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.无症状个体和 SARS-CoV-2 感染轻症患者的上呼吸道病毒载量。
Thorax. 2021 Jan;76(1):61-63. doi: 10.1136/thoraxjnl-2020-215042. Epub 2020 Sep 22.
7
Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations.环介导等温扩增结合纳米孔测序(LamPORE)在症状性和无症状人群中大规模检测 SARS-CoV-2 感染的诊断准确性。
Clin Microbiol Infect. 2021 Sep;27(9):1348.e1-1348.e7. doi: 10.1016/j.cmi.2021.04.008. Epub 2021 Apr 24.
8
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.SARS-CoV-2 血清流行率和高危密切接触者的传播风险因素:一项回顾性队列研究。
Lancet Infect Dis. 2021 Mar;21(3):333-343. doi: 10.1016/S1473-3099(20)30833-1. Epub 2020 Nov 2.
9
Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.评估 COVID-19 大流行期间孕妇的母婴 SARS-CoV-2 病毒载量、胎盘抗体转移和胎盘病理学。
JAMA Netw Open. 2020 Dec 1;3(12):e2030455. doi: 10.1001/jamanetworkopen.2020.30455.
10
Viral RNA Load and Infectivity of SARS-CoV-2 in Paired Respiratory and Oral Specimens from Symptomatic, Asymptomatic, or Postsymptomatic Individuals.从有症状、无症状或症状后个体的呼吸道和口腔配对标本中检测 SARS-CoV-2 的病毒 RNA 载量和感染力。
Microbiol Spectr. 2022 Jun 29;10(3):e0226421. doi: 10.1128/spectrum.02264-21. Epub 2022 May 16.

引用本文的文献

1
Hybrid analysis with phylogeny and population modeling to estimate the recent founding date of a population: A case study in the origins of COVID-19 illustrates how a branching process approximation can simplify a hybrid analysis.结合系统发育和种群建模进行混合分析以估计种群的近期奠基日期:以新冠病毒起源的案例研究说明分支过程近似法如何简化混合分析。
Math Biosci. 2025 Apr;382:109401. doi: 10.1016/j.mbs.2025.109401. Epub 2025 Feb 11.
2
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.东南亚抗击新冠病毒变异株倡议(SEACOVARIANTS)联盟
Wellcome Open Res. 2024 Apr 11;9:181. doi: 10.12688/wellcomeopenres.20742.1. eCollection 2024.
3

本文引用的文献

1
Erratum: Chest CT Findings in Cases from the Cruise Ship "Diamond Princess" with Coronavirus Disease 2019 (COVID-19).勘误:“钻石公主”号游轮上2019冠状病毒病(COVID-19)病例的胸部CT表现。
Radiol Cardiothorac Imaging. 2020 Apr 7;2(2):e204002. doi: 10.1148/ryct.2020204002. eCollection 2020 Apr.
2
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.在一家专业护理机构中出现的 SARS-CoV-2 感染前驱期和传播。
N Engl J Med. 2020 May 28;382(22):2081-2090. doi: 10.1056/NEJMoa2008457. Epub 2020 Apr 24.
3
Clinical Characteristics of Covid-19 in New York City.
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.
无声的战斗:无症状 SARS-CoV-2 感染中的免疫反应。
Cell Mol Immunol. 2024 Feb;21(2):159-170. doi: 10.1038/s41423-024-01127-z. Epub 2024 Jan 15.
4
COVID-19 immunity and vaccines: what a pharmacist needs to know.新冠病毒(COVID-19)免疫力与疫苗:药剂师需要了解的内容。
Asian Biomed (Res Rev News). 2021 Apr 30;15(2):51-67. doi: 10.2478/abm-2021-0008. eCollection 2021 Apr.
5
Sensitivity of nasopharyngeal swab and saliva specimens in the detection of SARS-CoV-2 virus among boarding school girls.寄宿学校女生中鼻咽拭子和唾液标本对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒检测的敏感性
IJID Reg. 2023 May 4;8(Suppl):S13-7. doi: 10.1016/j.ijregi.2023.02.009.
6
Quantification of early nonpharmaceutical interventions aimed at slowing transmission of Coronavirus Disease 2019 in the Navajo Nation and surrounding states (Arizona, Colorado, New Mexico, and Utah).对旨在减缓2019冠状病毒病在纳瓦霍族及周边各州(亚利桑那州、科罗拉多州、新墨西哥州和犹他州)传播的早期非药物干预措施的量化。
PLOS Glob Public Health. 2023 Jun 21;3(6):e0001490. doi: 10.1371/journal.pgph.0001490. eCollection 2023.
7
Recent advances in RNA sample preparation techniques for the detection of SARS-CoV-2 in saliva and gargle.用于检测唾液和漱口液中SARS-CoV-2的RNA样本制备技术的最新进展。
Trends Analyt Chem. 2023 Aug;165:117107. doi: 10.1016/j.trac.2023.117107. Epub 2023 May 23.
8
Quantification of early nonpharmaceutical interventions aimed at slowing transmission of Coronavirus Disease 2019 in the Navajo Nation and surrounding states (Arizona, Colorado, New Mexico, and Utah).对旨在减缓2019冠状病毒病在纳瓦霍族及周边各州(亚利桑那州、科罗拉多州、新墨西哥州和犹他州)传播的早期非药物干预措施的量化。
medRxiv. 2023 Feb 16:2023.02.15.23285971. doi: 10.1101/2023.02.15.23285971.
9
What is the burden of asymptomatic coronavirus infections?无症状冠状病毒感染的负担是什么?
New Microbes New Infect. 2023 Mar;52:101101. doi: 10.1016/j.nmni.2023.101101. Epub 2023 Feb 15.
10
High rates of observed face mask use at Colorado universities align with students' opinions about masking and support the safety and viability of in-person higher education during the COVID-19 pandemic.科罗拉多大学的口罩使用率很高,这与学生对戴口罩的看法一致,也支持了在 COVID-19 大流行期间进行面对面高等教育的安全性和可行性。
BMC Public Health. 2023 Feb 9;23(1):299. doi: 10.1186/s12889-023-15211-y.
纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
4
Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China.中国武汉新冠肺炎孕妇的临床特征
N Engl J Med. 2020 Jun 18;382(25):e100. doi: 10.1056/NEJMc2009226. Epub 2020 Apr 17.
5
Saliva: potential diagnostic value and transmission of 2019-nCoV.唾液:2019-nCoV 的潜在诊断价值和传播。
Int J Oral Sci. 2020 Apr 17;12(1):11. doi: 10.1038/s41368-020-0080-z.
6
Vietnam's response to COVID-19: prompt and proactive actions.越南对新冠疫情的应对:迅速且积极主动的行动。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa047.
7
Spread of SARS-CoV-2 in the Icelandic Population.SARS-CoV-2 在冰岛人群中的传播。
N Engl J Med. 2020 Jun 11;382(24):2302-2315. doi: 10.1056/NEJMoa2006100. Epub 2020 Apr 14.
8
Presymptomatic Transmission of SARS-CoV-2 - Singapore, January 23-March 16, 2020.2020 年 1 月 23 日至 3 月 16 日新加坡出现的 SARS-CoV-2 病前传播。
MMWR Morb Mortal Wkly Rep. 2020 Apr 10;69(14):411-415. doi: 10.15585/mmwr.mm6914e1.
9
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
10
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.